News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Antero Resources expects materially higher free cash flow in H2 2026.
  • Shares trade around $34.92, implying a steep discount to historical cyclic peaks.
  • Debt/equity stands near 0.31, reducing leverage risk.
  • EV/EBITDA sits near 6, pointing to a cheap valuation.
  • Report outlines entry, stop and target for a 180 trading-day horizon.

Latest Articles

Bank of England Seen Slowing Down Bond Sales Pace

Bank of England Seen Slowing Down Bond Sales Pace

A recent survey of market participants indicates the Bank of England is likely to reduce the annual pace at which it is shrinking its government bond holdings to £50 billion in the 12 months ending September 2027, compared with a £70 billion pace in the current 12-month period. The survey, released Friday, mirrors the central bank's previous Market…

Dubai crude premium edges higher as trading activity picks up

Dubai crude premium edges higher as trading activity picks up

Spot premiums for Dubai crude rose on Friday as trading volumes strengthened, while premiums for Oman and Murban retreated. Trafigura emerged as the dominant bidder during the session and had been the principal buyer in the prior two trading days. Shipping through the Strait of Hormuz remained limited despite two very large crude carriers transitin…

Moleculin’s MIRACLE R/R AML Trial Reports Positive Interim Data with 37% Blinded CRc in Venetoclax-Failed Patients

Moleculin’s MIRACLE R/R AML Trial Reports Positive Interim Data with 37% Blinded CRc in Venetoclax-Failed Patients

Moleculin Biotech announced positive interim blinded results from Part A of its pivotal Phase 2/3 MIRACLE trial evaluating Annamycin plus cytarabine for relapsed or refractory acute myeloid leukemia (AML). The trial showed a 37% composite complete remission rate (CRc) even in patients who failed prior venetoclax treatment, significantly outperformi…

Morgan Stanley Lowers China Growth Forecast After Weak June Activity

Morgan Stanley Lowers China Growth Forecast After Weak June Activity

Morgan Stanley trimmed its full-year China GDP forecast by 20 basis points to 4.6% after June activity expanded 4.3%, missing both consensus and Beijing's target. The bank pointed to decelerating infrastructure spending after front-loading, weaker refining and petrochemical output tied to oil prices, and subdued consumption driven by fading trade-i…

TSX Futures Tick Up as Earnings Flood the Market Ahead of Canada GDP Release

TSX Futures Tick Up as Earnings Flood the Market Ahead of Canada GDP Release

Futures linked to Canada’s main equity gauge inched higher on Friday as investors absorbed a heavy calendar of corporate results and positioned for upcoming domestic GDP figures. Strength in metal mining names, a rebound in U.S. technology and ongoing commodity swings underpinned the moves, while traders continued to weigh the Federal Reserve’s pol…

Goldman Sachs: European Corporate Earnings Outperform Expectations

Goldman Sachs: European Corporate Earnings Outperform Expectations

Goldman Sachs says European companies are topping earnings forecasts in the current reporting season, with roughly two-thirds of the STOXX Europe 600 having reported. Aggregate earnings-per-share surprises are running near 3%, and first-half EPS is tracking about 13% year-over-year - the fastest pace in three years. Sector revisions have mostly tre…

Oxford Square Capital Corp. Announces Net Asset Value and Selected Financial Results for the Quarter Ended June 30, 2026 and Declaration of Distributions on Common Stock for the Months Ending October 31, November 30, and December 31, 2026

Oxford Square Capital Corp. Announces Net Asset Value and Selected Financial Results for the Quarter Ended June 30, 2026 and Declaration of Distributions on Common Stock for the Months Ending October 31, November 30, and December 31, 2026

Oxford Square Capital Corp. announced its net asset value, financial results for Q2 2026, and declared common stock distributions for October through December 2026. The company reported a slight decline in NAV to $1.29 per share from $1.32, net investment income of approximately $5.1 million, and total investment income of $9.4 million for the quar…

Picard Medical / SynCardia Presents Emperor Total Artificial Heart Architecture for the First Time at IEEE EMBC 2026

Picard Medical / SynCardia Presents Emperor Total Artificial Heart Architecture for the First Time at IEEE EMBC 2026

Picard Medical, Inc., through its subsidiary SynCardia Systems, presented for the first time the integrated architecture of its Emperor Total Artificial Heart (Emperor TAH) at the IEEE EMBC 2026 conference. This next-generation system combines the proven SynCardia Total Artificial Heart ventricles with a new patent-pending Emperor Drive System (EDS…

Mobilicom to Report Financial and Operational Results for the Six Months Ended June 30, 2026, on Thursday, August 13, 2026

Mobilicom to Report Financial and Operational Results for the Six Months Ended June 30, 2026, on Thursday, August 13, 2026

Mobilicom Limited, a provider of cybersecurity and robust solutions for drones and robotics, announced that it will release its financial and operational results for the six months ended June 30, 2026, on August 13, 2026, after Nasdaq market close. A conference call and webcast will follow for management to discuss results and recent developments. …

Space-Eyes and McKinley Acquisition Corp. Announce Definitive Business Combination Agreement to Deliver AI-Driven Counter Drone Technology and Geospatial Intelligence Worldwide

Space-Eyes and McKinley Acquisition Corp. Announce Definitive Business Combination Agreement to Deliver AI-Driven Counter Drone Technology and Geospatial Intelligence Worldwide

Space-Eyes, a U.S.-based geospatial intelligence and AI-powered counter-unmanned aerial system provider, has agreed to merge with McKinley Acquisition Corp. in a business combination expected to close in Q4 2026. The combined company will trade on Nasdaq under the ticker CUAS with a pro forma equity valuation of $638 million. The transaction includ…

Wearable Devices Announces Pricing of $3.3 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Institutional Investor

Wearable Devices Announces Pricing of $3.3 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Institutional Investor

Wearable Devices Ltd. has entered into a private placement agreement with a single institutional investor to raise approximately $3.3 million through the issuance of 1,000,000 shares and accompanying warrants exercisable over five years. The capital raised will fund commercialization of Mudra products, development of next-generation devices, AI6 La…

Acorn – Provider of Monitoring and Control Solutions for Mission-Critical Assets Hosts Q2 Earnings Call Thursday Aug. 6th at 11am ET

Acorn – Provider of Monitoring and Control Solutions for Mission-Critical Assets Hosts Q2 Earnings Call Thursday Aug. 6th at 11am ET

Acorn Energy, Inc., through its subsidiary OmniMetrix, will report its Q2 2026 earnings and hold a conference call on August 6th. The company specializes in wireless remote monitoring and control solutions for critical infrastructure such as generators, gas pipelines, cell towers, and data centers, serving commercial, governmental, and residential …